|
Experience
David practices with Pierce Atwood's Intellectual Property Group. Prior to joining Pierce Atwood, David practiced with a Boston area IP Specialty firm drafting and prosecuting patents in biotechnology, pharmaceuticals, medical devices, research equipment and mechanical devices. Prior to entering the legal profession, David had a successful career in biotechnology and management.
Education
David has a B.S. in Biology with a Minor in Organic Chemistry from Bridgewater State College, an M.S. from the University of Vermont, Cell and Molecular Biology Program, a Ph.D. from the University of Vermont, Immunobiology Program, and a J.D. from Suffolk University Law School. While in law school, David was the recipient of the Suffolk Jurisprudence Award - Professional Responsibility.
Civic Activities
Troop Leader, Boy Scout Troop 5, Milton, MA
Publications
Wilson, D.J., Fortner, K.A., Lynch, D.H., Mattingly, R.R., Macara, I.G., Posada, J.A. and Budd, R.C. (1996). JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26:989-994.
Vincent, M.S., Roessner, K., Lynch, D., Wilson, D., Cooper, S.M., Tschoop, J., Sigal, L.H. and Budd, R.C. (1996). Apoptosis of Fas high CD4+ synovial T cells by Borrelia-reactive Fas-ligandhigh (*T cells in Lyme arthritis. J. Exp. Med. 164:2109-2117.
Wilson, D.J., Alessandrini, A, and Budd, R.C. (1999). ERK activation rescues T cells from Fas-induced apoptosis. Cellular Immunology. 194:67-77.
Bar Admissions
David is registered to practice by the Massachusetts State Bar and the United States Patent and Trademark Office.
Practice Areas
Intellectual Property
Related Practice Areas
Life Sciences
Patent
| 